Phoenixville, PA, United States of America

Jill S Gregory

This inventor holds 1 USPTO granted patent. Top assignee: Sterling Winthrop Inc.. Active years: 1997.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jill S Gregory

Introduction

Jill S Gregory is a notable inventor based in Phoenixville, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of Calpain inhibitors. Her work has the potential to impact various therapeutic areas.

Latest Patents

Jill holds a patent for a compound known as Quinolone carboxamide Calpain inhibitors. This compound is characterized by a specific formula wherein Z can be aryl, substituted aryl, phenyl-lower-alkyl, hetero-aryl, substituted heteroaryl, heterocycloalkyl, heterocyclocalkyl-lower-alkyl, or hetero-aryl-lower-alkyl. The innovation behind this patent is crucial for advancing medical treatments.

Career Highlights

Jill is currently associated with Sterling Winthrop Inc., where she continues to push the boundaries of pharmaceutical research. Her dedication to innovation has led her to develop a patent that showcases her expertise and commitment to improving health outcomes.

Collaborations

Throughout her career, Jill has collaborated with esteemed colleagues such as Roland Ellwood Dolle and Todd L Graybill. These partnerships have fostered a creative environment that encourages the exchange of ideas and advancements in their field.

Conclusion

Jill S Gregory's contributions to the field of pharmaceuticals through her innovative patent exemplify her role as a leading inventor. Her work not only highlights her expertise but also underscores the importance of collaboration in driving advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…